Efficacy Study of Polyethylene Glycol 3350-electrolyte Solution (GoLYTELY®) Versus Lactulose in Patients With Hepatic Encephalopathy.



Status:Archived
Conditions:Infectious Disease, Neurology, Psychiatric, Gastrointestinal
Therapuetic Areas:Gastroenterology, Immunology / Infectious Diseases, Neurology, Psychiatry / Psychology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:January 2011
End Date:January 2013

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Randomized Controlled Trial Evaluating the Efficacy of Polyethylene Glycol 3350-electrolyte Solution (GoLYTELY®) in Patients With Hepatic Encephalopathy.


This study is being done to find out if the laxative polyethylene glycol (also known as
GoLYTELY® or Miralax®) can treat your hepatic encephalopathy (confusion due to your liver
disease and/or cirrhosis) better and/or more safely than lactulose (another laxative). In
this study, the investigators will evaluate if polyethylene glycol (GoLYTELY®) is more
effective than lactulose on neurocognition (memory and thinking skills) and determine if it
decreases the hospital stay.



We found this trial at
1
site
UT Soutwestern Medical Center at Dallas
5303 Harry Hines Boulevard
Dallas, Texas 75390
(214) 648-3111
UT Soutwestern Medical Center at Dallas UT Southwestern Medical Center is distinctive for its overall...
911
mi
from 43215
Dallas, TX
Click here to add this to my saved trials